Vault-13

Soleus Capital Management, L.P.

GREENWICH, CT · CIK 1802630 · 13F filing filed 2022-08-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$624.3m reported value -3.7% vs Q1 2022
71positions
44.3%in top 10
22 new 22 added 22 reduced 15 sold out vs Q1 2022

Options: 1 call positions ($16.7m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 295,541 $69.6m11.15% 11.15% ReducedShares held: Q3 2021 101.8k, Q4 2021 164.3k, Q1 2022 305.9k, Q2 2022 295.5k -10.3k -10,309 -3.4%
2 THE BEAUTY HEALTH COMPANY COM CL A COM CL A 3,276,037 $42.1m6.75% 6.75% AddedShares held: Q3 2021 202.0k, Q4 2021 0, Q1 2022 227.6k, Q2 2022 3.3m +3.0m +3,048,425 1339.3%
3 ORGANOGENESIS HLDGS INC COM ORGO ORGO 5,286,167 $25.8m4.13% 4.13% AddedShares held: Q3 2021 639.9k, Q4 2021 2.0m, Q1 2022 2.5m, Q2 2022 5.3m +2.7m +2,746,000 108.1%
4 SURMODICS INC COM SRDX SRDX 661,004 $24.6m3.94% 3.94% AddedShares held: Q3 2021 381.5k, Q4 2021 532.8k, Q1 2022 558.4k, Q2 2022 661.0k +102.6k +102,564 18.4%
5 EDAP TMS S A SPONSORED ADR FOCL FOCL 3,284,189 $22.3m3.58% 3.58% AddedShares held: Q3 2021 3.0m, Q4 2021 3.1m, Q1 2022 3.1m, Q2 2022 3.3m +135.6k +135,580 4.3%
6 IRADIMED CORP COM IRMD IRMD 620,765 $21.1m3.37% 3.37% AddedShares held: Q3 2021 450.7k, Q4 2021 450.0k, Q1 2022 430.1k, Q2 2022 620.8k +190.7k +190,714 44.4%
7 CVS HEALTH CORP COM CVS CVS 219,400 $20.3m3.26% 3.26% AddedShares held: Q3 2021 0, Q4 2021 138.0k, Q1 2022 92.5k, Q2 2022 219.4k +126.9k +126,900 137.2%
8 THERATECHNOLOGIES INC COM COM 7,822,412 $17.8m2.84% 2.84% AddedShares held: Q3 2021 7.6m, Q4 2021 7.7m, Q1 2022 7.7m, Q2 2022 7.8m +130.3k +130,330 1.7%
9 ARCELLX INC COMMON STOCK ACLX ACLX 909,739 $16.4m2.63% 2.63% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 989.7k, Q2 2022 909.7k -80.0k -80,000 -8.1%
10 INSPIRE MED SYS INC COM INSP INSP 88,950 $16.2m2.60% 2.60% AddedShares held: Q3 2021 30.9k, Q4 2021 27.4k, Q1 2022 47.9k, Q2 2022 89.0k +41.0k +41,050 85.7%
11 KRYSTAL BIOTECH INC COM KRYS KRYS 214,482 $14.1m2.26% 2.26% ReducedShares held: Q3 2021 125.5k, Q4 2021 228.4k, Q1 2022 289.3k, Q2 2022 214.5k -74.9k -74,855 -25.9%
12 ESSA PHARMA INC COM NEW EPI EPI 4,168,799 $13.1m2.10% 2.10% ReducedShares held: Q3 2021 2.9m, Q4 2021 3.5m, Q1 2022 4.2m, Q2 2022 4.2m -55.0k -55,000 -1.3%
13 ANAPTYSBIO INC COM ANAB ANAB 643,575 $13.1m2.09% 2.09% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 643.6k
14 ANGIODYNAMICS INC COM ANGO ANGO 670,000 $13.0m2.08% 2.08% ReducedShares held: Q3 2021 242.5k, Q4 2021 515.5k, Q1 2022 1.0m, Q2 2022 670.0k -356.4k -356,450 -34.7%
15 DICE THERAPEUTICS INC COM COM 815,740 $12.7m2.03% 2.03% ReducedShares held: Q3 2021 879.9k, Q4 2021 810.9k, Q1 2022 984.0k, Q2 2022 815.7k -168.3k -168,254 -17.1%
16 NURIX THERAPEUTICS INC COM NRIX NRIX 994,492 $12.6m2.02% 2.02% ReducedShares held: Q3 2021 263.9k, Q4 2021 743.2k, Q1 2022 1.0m, Q2 2022 994.5k -17.1k -17,146 -1.7%
17 APOLLO ENDOSURGERY INC COM COM 3,268,948 $11.9m1.91% 1.91% AddedShares held: Q3 2021 0, Q4 2021 2.3m, Q1 2022 2.9m, Q2 2022 3.3m +375.8k +375,848 13.0%
18 NEUROPACE INC COM NPCE NPCE 2,334,003 $11.6m1.85% 1.85% AddedShares held: Q3 2021 1.7m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m +10.0k +10,000 0.4%
19 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 169,696 $11.2m1.80% 1.80% AddedShares held: Q3 2021 319.4k, Q4 2021 478.6k, Q1 2022 112.7k, Q2 2022 169.7k +57.0k +57,000 50.6%
20 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 183,800 $10.9m1.74% 1.74% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 183.8k
21 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 841,018 $9.7m1.56% 1.56% AddedShares held: Q3 2021 0, Q4 2021 90.0k, Q1 2022 90.0k, Q2 2022 841.0k +751.0k +751,018 834.5%
22 CUTERA INC COM CUTR CUTR 257,600 $9.7m1.55% 1.55% NewShares held: Q3 2021 14.5k, Q4 2021 86.2k, Q1 2022 0, Q2 2022 257.6k
23 EVOLUS INC COM EOLS EOLS 810,676 $9.4m1.51% 1.51% ReducedShares held: Q3 2021 642.9k, Q4 2021 1.3m, Q1 2022 1.4m, Q2 2022 810.7k -557.7k -557,713 -40.8%
24 BIOATLA INC COM BCAB BCAB 3,262,703 $9.3m1.49% 1.49% AddedShares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 3.3m +747.3k +747,279 29.7%
25 IVERIC BIO INC COM OPHT OPHT 914,346 $8.8m1.41% 1.41% ReducedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 964.5k, Q2 2022 914.3k -50.1k -50,130 -5.2%
26 PENUMBRA INC COM PEN PEN 68,800 $8.6m1.37% 1.37% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 68.8k
27 VAXCYTE INC COM PCVX PCVX 370,650 $8.1m1.29% 1.29% AddedShares held: Q3 2021 355.6k, Q4 2021 294.8k, Q1 2022 328.4k, Q2 2022 370.6k +42.3k +42,300 12.9%
28 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 719,600 $7.9m1.27% 1.27% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 719.6k
29 PIERIS PHARMACEUTICALS INC COM COM 4,134,868 $7.7m1.24% 1.24% UnchangedShares held: Q3 2021 740.0k, Q4 2021 687.4k, Q1 2022 4.1m, Q2 2022 4.1m
30 STERIS PLC SHS USD STE STE 37,310 $7.7m1.23% 1.23% ReducedShares held: Q3 2021 0, Q4 2021 52.1k, Q1 2022 41.3k, Q2 2022 37.3k -4.0k -3,950 -9.6%
31 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 258,100 $7.5m1.20% 1.20% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 251.0k, Q2 2022 258.1k +7.1k +7,100 2.8%
32 CVRX INC COM CVRX CVRX 1,059,040 $6.4m1.02% 1.02% AddedShares held: Q3 2021 619.1k, Q4 2021 962.2k, Q1 2022 962.2k, Q2 2022 1.1m +96.9k +96,875 10.1%
33 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 77,842 $6.2m0.99% 0.99% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 77.8k
34 INCYTE CORP COM INCY INCY 79,700 $6.1m0.97% 0.97% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 79.7k
35 TRANSMEDICS GROUP INC COM TMDX TMDX 184,455 $5.8m0.93% 0.93% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 184.5k
36 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 846,000 $5.3m0.85% 0.85% AddedShares held: Q3 2021 213.5k, Q4 2021 0, Q1 2022 783.0k, Q2 2022 846.0k +63.0k +63,000 8.1%
37 STAAR SURGICAL CO COM PAR $0.01 STAA STAA 75,094 $5.3m0.85% 0.85% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 75.1k
38 INARI MED INC COM NARI NARI 72,298 $4.9m0.79% 0.79% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 72.3k
39 FATE THERAPEUTICS INC COM FATE FATE 194,400 $4.8m0.77% 0.77% ReducedShares held: Q3 2021 0, Q4 2021 7.8k, Q1 2022 205.9k, Q2 2022 194.4k -11.5k -11,500 -5.6%
40 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 100,000 $4.7m0.76% 0.76% ReducedShares held: Q3 2021 182.4k, Q4 2021 318.3k, Q1 2022 202.5k, Q2 2022 100.0k -102.5k -102,485 -50.6%
41 EXACT SCIENCES CORP COM EXAS EXAS 119,000 $4.7m0.75% 0.75% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 119.0k
42 NATERA INC COM NTRA NTRA 131,873 $4.7m0.75% 0.75% ReducedShares held: Q3 2021 139.0k, Q4 2021 227.6k, Q1 2022 155.0k, Q2 2022 131.9k -23.1k -23,127 -14.9%
43 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 318,100 $4.4m0.70% 0.70% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 318.1k
44 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 78,400 $4.3m0.68% 0.68% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 78.4k
45 INMODE LTD SHS INMD INMD 187,449 $4.2m0.67% 0.67% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 146.5k, Q2 2022 187.4k +40.9k +40,949 27.9%
46 PLIANT THERAPEUTICS INC COM PLRX PLRX 490,000 $3.9m0.63% 0.63% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 240.0k, Q2 2022 490.0k +250.0k +250,000 104.2%
47 CHEMOCENTRYX INC COM CCXI CCXI 154,400 $3.8m0.61% 0.61% NewShares held: Q3 2021 0, Q4 2021 68.3k, Q1 2022 0, Q2 2022 154.4k
48 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 196,018 $3.8m0.61% 0.61% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 343.5k, Q2 2022 196.0k -147.5k -147,482 -42.9%
49 CELCUITY INC COM CELC CELC 418,912 $3.8m0.61% 0.61% AddedShares held: Q3 2021 83.7k, Q4 2021 32.1k, Q1 2022 32.1k, Q2 2022 418.9k +386.8k +386,839 1206.1%
50 LANTHEUS HLDGS INC COM LNTH LNTH 55,222 $3.6m0.58% 0.58% ReducedShares held: Q3 2021 1.2m, Q4 2021 1.8m, Q1 2022 178.4k, Q2 2022 55.2k -123.2k -123,205 -69.0%
51 DEXCOM INC COM DXCM DXCM 47,236 $3.5m0.56% 0.56% AddedShares held: Q3 2021 0, Q4 2021 31.0k, Q1 2022 46.4k, Q2 2022 47.2k +800 +800 1.7%
52 LYRA THERAPEUTICS INC COM LYRA LYRA 592,417 $3.3m0.54% 0.54% NewShares held: Q3 2021 215.6k, Q4 2021 10.0k, Q1 2022 0, Q2 2022 592.4k
53 FIBROGEN INC COM COM 302,226 $3.2m0.51% 0.51% ReducedShares held: Q3 2021 0, Q4 2021 1.6m, Q1 2022 1.1m, Q2 2022 302.2k -762.1k -762,130 -71.6%
54 IO BIOTECH INC COM IOBTQ IOBTQ 655,404 $3.1m0.49% 0.49% ReducedShares held: Q3 2021 0, Q4 2021 672.7k, Q1 2022 672.7k, Q2 2022 655.4k -17.3k -17,330 -2.6%
55 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 20,100 $2.9m0.47% 0.47% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 20.1k
56 XENON PHARMACEUTICALS INC COM XENE XENE 75,000 $2.3m0.37% 0.37% ReducedShares held: Q3 2021 215.7k, Q4 2021 379.0k, Q1 2022 189.8k, Q2 2022 75.0k -114.8k -114,797 -60.5%
57 C4 THERAPEUTICS INC COM STK CCCC CCCC 282,640 $2.1m0.34% 0.34% AddedShares held: Q3 2021 750.6k, Q4 2021 561.1k, Q1 2022 166.7k, Q2 2022 282.6k +115.9k +115,904 69.5%
58 KEZAR LIFE SCIENCES INC COM COM 252,000 $2.1m0.33% 0.33% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 252.0k
59 Y-MABS THERAPEUTICS INC COM YMAB YMAB 136,182 $2.1m0.33% 0.33% ReducedShares held: Q3 2021 265.7k, Q4 2021 310.5k, Q1 2022 239.0k, Q2 2022 136.2k -102.8k -102,800 -43.0%
60 VERASTEM INC COM COM 1,644,500 $1.9m0.31% 0.31% UnchangedShares held: Q3 2021 0, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
61 PEPGEN INC COM PEPG PEPG 175,000 $1.7m0.28% 0.28% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 175.0k
62 CHINOOK THERAPEUTICS INC COM ADRO ADRO 88,000 $1.5m0.25% 0.25% NewShares held: Q3 2021 0, Q4 2021 298.7k, Q1 2022 0, Q2 2022 88.0k
63 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 22,000 $1.3m0.21% 0.21% UnchangedShares held: Q3 2021 92.2k, Q4 2021 22.0k, Q1 2022 22.0k, Q2 2022 22.0k
64 XILIO THERAPEUTICS INC COM COM 453,660 $1.3m0.21% 0.21% ReducedShares held: Q3 2021 0, Q4 2021 477.5k, Q1 2022 477.5k, Q2 2022 453.7k -23.8k -23,835 -5.0%
65 CULLINAN THERAPEUTICS INC COM CGEM CGEM 95,485 $1.2m0.20% 0.20% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 95.5k
66 BRIDGEBIO PHARMA INC NOTE 2.500% 3/1 · principal BBIO 2.5 03.15.27 · principal BBIO 2.5 03.15.27 1,950,000 $1.1m0.17% 0.17% UnchangedPrincipal held: Q3 2021 1.9m, Q4 2021 1.9m, Q1 2022 1.9m, Q2 2022 1.9m
67 OUTSET MED INC COM OM OM 69,200 $1.0m0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 69.2k
68 NOVOCURE LTD ORD SHS NVCR NVCR 13,275 $923.0k0.15% 0.15% ReducedShares held: Q3 2021 27.3k, Q4 2021 22.3k, Q1 2022 17.3k, Q2 2022 13.3k -4.0k -4,000 -23.1%
69 IMMUNIC INC COM COM 240,000 $833.0k0.13% 0.13% UnchangedShares held: Q3 2021 0, Q4 2021 175.0k, Q1 2022 240.0k, Q2 2022 240.0k
70 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 825,000 $726.0k0.12% 0.12% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 825.0k
71 DA32 LIFE SCNCE TEC ACQSTN C CLASS A COM CLASS A COM 50,000 $485.0k0.08% 0.08% ReducedShares held: Q3 2021 350.0k, Q4 2021 350.0k, Q1 2022 100.0k, Q2 2022 50.0k -50.0k -50,000 -50.0%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
ILLUMINA INC ILMN ILMN 62,300 $21.8m62.3k shares
ORASURE TECHNOLOGIES INC OSUR OSUR 3,055,193 $20.7m3.1m shares
HOLOGIC INC HOLX HOLX 225,600 $17.3m225.6k shares
SMITH & NEPHEW PLC SNN SNN 385,000 $12.3m385.0k shares
10X GENOMICS INC TXG TXG 106,139 $8.1m106.1k shares
NEOGENOMICS INC NEO NEO 460,000 $5.6m460.0k shares
SIENTRA INC SIEN SIEN 1,641,337 $3.6m1.6m shares
ARYA SCIENCES ACQU CORP IV 300,000 $2.9m300.0k shares
INTUITIVE SURGICAL INC ISRG ISRG 7,800 $2.4m7.8k shares
CELLDEX THERAPEUTICS INC NEW CLDX CLDX 69,000 $2.4m69.0k shares
LIQUIDIA CORPORATION LQDA LQDA 293,485 $2.1m293.5k shares
CYTEK BIOSCIENCES INC CTKB CTKB 180,000 $1.9m180.0k shares
CARA THERAPEUTICS INC 159,200 $1.9m159.2k shares
PACIRA BIOSCIENCES INC PCRX PCRX 22,250 $1.7m22.2k shares
OLINK HLDG AB 53,961 $953.0k54.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
THE BEAUTY HEALTH COMPANY Call Call 1,300,000 $16.7m1.3m shares New